Misra Shubham, Kumar Pradeep, Kumar Amit, Sagar Ram, Chakravarty Kamalesh, Prasad Kameshwar
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Meta Gene. 2016 Jan 19;8:21-9. doi: 10.1016/j.mgene.2016.01.003. eCollection 2016 Jun.
Sequence variations in genes involved in inflammatory system are known to contribute to the risk of cerebrovascular diseases (CVD) including stroke. Very few number of studies have been published in the context of the association between Interleukin-1α(IL-1α), CD14 cell surface glycoprotein (CD14), Galectin-2-encoding gene (LGALS2)and proteasome subunit type 6 (PSMA6) gene polymorphisms with susceptibility to ischemic stroke (IS).
The present meta-analysis aimed to provide a comprehensive account of the association between IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and PSMA6 (-C8G) gene polymorphisms and susceptibility to IS.
A literature search for eligible genetic studies published before August 31, 2015 was conducted in the PubMed, Medline, EMBASE, OVID, and Google Scholar databases. Fixed or random effects models were used to estimate the Pooled Odds ratio (OR) and 95% confidence interval (CI) using RevMan 5.3 software.
Total 21 studies were included in our meta-analysis. No significant association was observed between IL-1α (-C889T) [OR = 1.18, 95% CI: 0.67-2.08, P = 0.58], IL-1α (-C511T) [OR = 0.95, 95% CI: 0.66-1.37, P = 0.77], LGALS2(-C2379T) [OR = 0.29, 95% CI: 0.02-4.26, P = 0.37] and CD14 (-C260T) [OR = 0.93, 95% CI: 0.77-1.11, P = 0. 42] gene polymorphisms and risk of IS. However, protective level of association was observed between PSMA6 (-C8G) gene polymorphism and susceptibility to IS under the recessive model [OR = 0.25, 95% CI: 0.08-0.72, P = 0.01].
Our meta-analysis shows that IL-1α (-C889T and -C511T), CD14 (-C159T), LGALS2 (-C3279T) and gene polymorphisms are not significantly associated with the risk of IS while PSMA6 (-C8G) gene polymorphism may play a protective role with the susceptibility of IS. Further prospective large epidemiological studies are needed to confirm these findings in different populations.
已知参与炎症系统的基因序列变异会增加包括中风在内的脑血管疾病(CVD)的风险。关于白细胞介素-1α(IL-1α)、CD14细胞表面糖蛋白(CD14)、半乳糖凝集素-2编码基因(LGALS2)和蛋白酶体亚基6型(PSMA6)基因多态性与缺血性中风(IS)易感性之间的关联,发表的研究极少。
本荟萃分析旨在全面阐述IL-1α(-C889T和-C511T)、CD14(-C159T)、LGALS2(-C3279T)和PSMA6(-C8G)基因多态性与IS易感性之间的关联。
在PubMed、Medline、EMBASE、OVID和谷歌学术数据库中检索2015年8月31日前发表的符合条件的基因研究。使用RevMan 5.3软件,采用固定或随机效应模型估计合并比值比(OR)和95%置信区间(CI)。
我们的荟萃分析共纳入21项研究。未观察到IL-1α(-C889T)[OR = 1.18,95% CI:0.67 - 2.08,P = 0.58]、IL-1α(-C511T)[OR = 0.95,95% CI:0.66 - 1.37,P = 0.77]、LGALS2(-C2379T)[OR = 0.29,95% CI:0.02 - 4.26,P = 0.37]和CD14(-C260T)[OR = 0.93,95% CI:0.77 - 1.11,P = 0.42]基因多态性与IS风险之间存在显著关联。然而,在隐性模型下观察到PSMA6(-C8G)基因多态性与IS易感性之间存在保护性关联[OR = 0.25,95% CI:0.08 - 0.72,P = 0.01]。
我们的荟萃分析表明,IL-1α(-C889T和-C511T)、CD14(-C159T)、LGALS2(-C3279T)基因多态性与IS风险无显著关联,而PSMA6(-C8G)基因多态性可能对IS易感性起保护作用。需要进一步开展前瞻性大型流行病学研究,在不同人群中证实这些发现。